Levodopa, Carbidopa, and Pyridoxine in Parkinson Disease

A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

1962 • 2,236 citations

The fluorometric assay of catecholamines and related compounds: Improvements and extensions to the hydroxyindole technique

1968 • 693 citations

The effect of tropolone on the formation of 3,4‐dihydroxyphenylacetic acid and 4‐hydroxy‐3‐methoxyphenylacetic acid in the brain of the mouse

1969 • 201 citations

The quantitative determination of 3-methoxy-4-hydroxyphenylacetic acid (homovanillic acid) in urine.

1965 • 87 citations

Pyridoxine reversal of L-dopa effects in Parkinsonism.

1969 • 70 citations

The Estimation of Total (Free + Conjugated) Catecholamines and Some Catecholamine Metabolites in Human Urine

1968 • 56 citations

Modification of Levodopa Effect by Systemic Decarboxylase Inhibition

1973 • 41 citations

Blocking the Negative Effects of Pyridoxine on Patients Receiving Levodopa

1971 • 31 citations

L‐DOPA: Effect on cerebral pyridoxal phosphate content and coenzyme activity

1971 • 30 citations

THE INVERSE RELATIONSHIP BETWEEN THE ACTIVITY OF PYRIDOXAL KINASE AND THE LEVEL OF BIOGENIC AMINES IN RABBIT BRAIN¹

1968 • 28 citations

L-DOPA AS A VITAMIN-B6 ANTAGONIST

1971 • 26 citations

Appraisal of current methods to estimate the turnover rate of serotonin and catecholamines in human brain.

1972 • 8 citations

The effect of pyridoxine deficiency on L-aromatic amino acid decarboxylase and tyrosine aminotransferase in developing brain.

1972 • 7 citations

Pyridoxine, DOPA, and Parkinsonism.

1972 • 7 citations

Levadopa and pyridoxine

1972 • 4 citations